At Molefy Pharma, we are developing a groundbreaking therapeutic solution to halt and reverse the progression of ALS. We are currently in an active fundraising phase and are open to engaging with visionary investors who share our mission of accelerating the path toward an effective treatment.
Whether you are an institutional investor, venture capital firm, or private backer passionate about high-impact science, we invite you to join us. Together, we can bring real hope to ALS patients and their families.
We are honored to collaborate with a growing network of institutions and organizations committed to advancing ALS research and treatment.